Literature DB >> 23999905

A diagnostic algorithm to identify paired tumors with clonal origin.

Szilárd Nemes1, Anna Danielsson, Toshima Z Parris, Junmei Miao Jonasson, Erik Bülow, Per Karlsson, Gunnar Steineck, Khalil Helou.   

Abstract

Despite practical implications we still lack standardized methods for clonality testing of tumor pairs. Each tumor is characterized by a set of chromosomal abnormalities, nonrandom changes preferentially involving specific chromosomes and chromosomal regions. Although tumors accumulate chromosomal abnormalities during their development, the majority of these alterations is specific and characteristic for each individual tumor is not exhibited at the population level. Assumingly, secondary tumors that develop from disseminated cells from the primary tumor inherit not only chromosomal changes specific for the cancerous process but also random chromosomal changes that accumulate during tumor development. Based on this assumption, we adopted an intuitive index for genomic similarities of paired tumors, which ranges between zero (completely different genomic profiles) and one (identical genomic profiles). To test the assumption that two tumors have clonal origins if they share a higher degree of genomic similarity than two randomly paired tumors, we built a permutation-based null-hypothesis procedure. The procedure is demonstrated using two publicly available data sets. The article highlights the complexities of clonality testing and aims to offer an easy to follow blueprint that will allow researchers to test genomic similarities of paired tumors, with the proposed index or any other index that fits their need.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23999905     DOI: 10.1002/gcc.22096

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.

Authors:  Kelly L Harms; Lorena Lazo de la Vega; Daniel H Hovelson; Samantha Rahrig; Andi K Cani; Chia-Jen Liu; Douglas R Fullen; Min Wang; Aleodor A Andea; Christopher K Bichakjian; Timothy M Johnson; Scott A Tomlins; Paul W Harms
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

2.  Clonal relatedness in tumour pairs of breast cancer patients.

Authors:  Jana Biermann; Toshima Z Parris; Szilárd Nemes; Anna Danielsson; Hanna Engqvist; Elisabeth Werner Rönnerman; Eva Forssell-Aronsson; Anikó Kovács; Per Karlsson; Khalil Helou
Journal:  Breast Cancer Res       Date:  2018-08-09       Impact factor: 6.466

3.  Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis.

Authors:  Shupeng Liu; Zaixin Zhou; Yin Jia; Jie Xue; Zhiyong Liu; Kai Cheng; Shuqun Cheng; Shanrong Liu
Journal:  Cancer Biol Med       Date:  2019-02       Impact factor: 4.248

4.  Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors.

Authors:  Paul W Harms; Monique E Verhaegen; Kevin Hu; Steven M Hrycaj; May P Chan; Chia-Jen Liu; Marina Grachtchouk; Rajiv M Patel; Aaron M Udager; Andrzej A Dlugosz
Journal:  Mod Pathol       Date:  2021-09-30       Impact factor: 7.842

5.  Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.

Authors:  Lei Bao; Karen Messer; Richard Schwab; Olivier Harismendy; Minya Pu; Brian Crain; Shawn Yost; Kelly A Frazer; Brinda Rana; Farnaz Hasteh; Anne Wallace; Barbara A Parker
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

6.  Genetic alterations associated with multiple primary malignancies.

Authors:  Jenny Nyqvist; Anikó Kovács; Zakaria Einbeigi; Per Karlsson; Eva Forssell-Aronsson; Khalil Helou; Toshima Z Parris
Journal:  Cancer Med       Date:  2021-05-31       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.